Australia markets open in 2 hours 32 minutes
  • ALL ORDS

    7,222.50
    -7.30 (-0.10%)
     
  • AUD/USD

    0.6431
    +0.0077 (+1.22%)
     
  • ASX 200

    7,024.80
    -5.50 (-0.08%)
     
  • OIL

    91.81
    -1.87 (-2.00%)
     
  • GOLD

    1,881.70
    -9.20 (-0.49%)
     
  • Bitcoin AUD

    41,917.45
    +1,066.73 (+2.61%)
     
  • CMC Crypto 200

    581.30
    +16.50 (+2.92%)
     

3 No-Brainer Stocks to Buy for Under $100 Right Now

3 No-Brainer Stocks to Buy for Under $100 Right Now

Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Novocure (NASDAQ: NVCR), and Pfizer (NYSE: PFE). David Jagielski (CRISPR Therapeutics): Shares of CRISPR Therapeutics are trading below $70, but it may not be long before they take off. The company has a promising gene-editing therapy in exa-cel for rare blood disorders beta-thalassemia and sickle cell disease that it has been working on with Vertex Pharmaceuticals.